Literature DB >> 9034222

Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.

P Santi1, P Colombo, R Bettini, P L Catellani, A Minutello, N M Volpato.   

Abstract

PURPOSE: The aim of the work was to study iontophoretic transdermal administration of salmon calcitonin (sCt) in rabbits, with particular attention to drug reservoir composition. A dry sCt disc, to be dissolved on the application site, was used for preparing the reservoir for transdermal iontophoresis. As a reference drug reservoir, a pad wetted with drug solution was used.
METHODS: Experiments were done in rabbits depositing 100 IU of salmon calcitonin on skin and applying anodal iontophoresis. Serum calcium concentration was measured during iontophoresis, passive diffusion and after i.v. administration. Parameters such as pH value and reservoir type were examined.
RESULTS: Transdermal iontophoresis of sCt elicited a decrease in the serum calcium level, whereas, in the absence of electric current, no significant fall was measured. Using the reservoir prepared from drug solution, anodal iontophoresis at pH 4.2 was more effective than at pH 7.4, probably due to higher sCt net positive charge. Using the reservoir prepared from dry disc, similar kinetics and extent of drug effect were observed at both pH values. The reservoir prepared from solid drug deposit concentrated sCt next to the skin.
CONCLUSIONS: Anodal iontophoresis for transdermal calcitonin administration shows therapeutical applicability. The type of reservoir is an important parameter affecting sCt transdermal iontophoresis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034222     DOI: 10.1023/a:1012055401038

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Degradation of synthetic salmon calcitonin in aqueous solution.

Authors:  K C Lee; Y J Lee; H M Song; C J Chun; P P DeLuca
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Total serum calcium concentrations in rabbits.

Authors:  D L Goad; M E Pecquet; H B Warren
Journal:  J Am Vet Med Assoc       Date:  1989-06-01       Impact factor: 1.936

3.  Percutaneous absorption of elcatonin and hypocalcemic effect in rat.

Authors:  T Ogiso; M Iwaki; I Yoneda; M Horinouchi; K Yamashita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-02       Impact factor: 1.645

4.  Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.

Authors:  P J Sinko; C L Smith; L T McWhorter; W Stern; E Wagner; J P Gilligan
Journal:  J Pharm Sci       Date:  1995-11       Impact factor: 3.534

5.  Convective solvent flow across the skin during iontophoresis.

Authors:  A Kim; P G Green; G Rao; R H Guy
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.

Authors:  A K Banga; Y W Chien
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.

Authors:  N G Schipper; S G Romeijn; J Verhoef; F W Merkus
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

8.  Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats.

Authors:  K Morimoto; Y Iwakura; E Nakatani; M Miyazaki; H Tojima
Journal:  J Pharm Pharmacol       Date:  1992-03       Impact factor: 3.765

9.  Correlation of calcitonin structure with chromatographic retention in high-performance liquid chromatography.

Authors:  M L Heinitz; E Flanigan; R C Orlowski; F E Regnier
Journal:  J Chromatogr       Date:  1988-06-29

10.  Influence of the mobile phase on salmon calcitonin analysis by reversed-phase liquid chromatography.

Authors:  I H Lee; S Pollack; S H Hsu; J R Miksic
Journal:  J Chromatogr Sci       Date:  1991-04       Impact factor: 1.618

View more
  1 in total

1.  Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.